Overview

Impact of Beta-blockers on Physical Function in HFpEF

Status:
Enrolling by invitation
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand the impact of beta-blockers on physical function in older adults with heart failure. We will achieve this objective by conducting N-of-1 trials. N-of-1 trials are personalized experiments that test different treatment options in an individual patient.
Phase:
Phase 4
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
The New York Community Trust
Treatments:
Acebutolol
Adrenergic beta-Antagonists
Atenolol
Betaxolol
Bisoprolol
Carvedilol
Labetalol
Metoprolol
Nadolol
Nebivolol
Penbutolol
Pindolol
Propranolol
Sotalol